GlassScriptPhysician profile
Howard K Robinson
NPI 1295721231
$4,755.40
in general payments reported to CMS, 2019-2025
37 companies · $826 in 2025
The $826 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $749 · 2020: $392 · 2021: $816 · 2022: $457 · 2023: $1,199 · 2024: $316 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,052 · Travel and Lodging: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,051.66 |
| Travel and Lodging | $289.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $964.16 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $655.80 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Curonix LLC | $488.62 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $426.25 | 2019-2025 | Relistor |
| Forte Bio-Pharma LLC | $366.88 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Medtronic USA, INC. | $246.42 | 2019-2020 | |
| Abbott Laboratories | $246.16 | 2019-2025 | Eterna |
| Collegium Pharmaceutical, INC. | $162.30 | 2019-2022 | |
| Horizon Therapeutics Plc | $110.86 | 2020-2021 | |
| Vertos Medical, INC. | $101.35 | 2023-2024 | Mild Device Kit |
| Grt US Holding, INC. | $84.71 | 2022 | |
| Biotronik Nro, INC. | $79.54 | 2024-2025 | Prospera |
| Redhill Biopharma INC. | $70.11 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $64.26 | 2025 | |
| Sentynl Therapeutics, INC. | $63.50 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $63.12 | 2023-2024 | Sprint Pns System |
| Vertiflex, INC. | $62.64 | 2019 | |
| Daiichi Sankyo INC. | $61.27 | 2019 | |
| Azurity Pharmaceuticals, INC. | $54.65 | 2023-2024 | Horizant, Horizant |
| Nevro Corp. | $38.35 | 2021-2023 | Senza |
| Convatec INC. | $37.61 | 2025 | |
| Averitas Pharma INC. | $34.77 | 2025 | Qutenza |
| Idorsia Pharmaceuticals US INC | $31.04 | 2022-2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $30.96 | 2019 | |
| Virtus Pharmaceuticals LLC | $22.73 | 2023 | Levorphanol Tartrate |
| Ge Healthcare | $20.94 | 2022 | |
| Protega Pharmaceutials INC | $18.79 | 2024 | Roxybond |
| Pfizer INC. | $18.43 | 2019 | |
| Spinal Simplicity, LLC | $18.06 | 2023 | Ha Minuteman G3-R |
| Shionogi INC | $16.51 | 2019 | |
| Valinor Pharma, LLC | $15.91 | 2025 | Movantik |
| Pacira Pharmaceuticals Incorporated | $15.78 | 2025 | Zilretta, Iovera |
| Scilex Pharmaceuticals INC. | $14.50 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $14.00 | 2019 | |
| Baudax Bio INC. | $11.79 | 2021 | |
| Radius Health, INC. | $11.41 | 2021 | |
| Mml US, INC. | $11.22 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.